Natalia Borinshteyn, MD, PhD

Natalia Borinshteyn, MD, PhD, is Founder and President of Life Science Excellence Inc., a boutique strategic consulting firm supporting pharmaceutical, biotech, and medical device companies. She brings more than 20 years of experience across clinical development, medical affairs, and commercial strategy, and has contributed to the development and launch of multiple innovative therapies across dermatology, immunology, gastroenterology, diabetes, and HCV.Previously, Dr. Borinshteyn served as Vice President of the HCV Launch Team at AbbVie, where she led Global and US Medical Affairs and played a key role in launch readiness and execution. Earlier in her career, she held leadership roles at Sanofi across clinical development, portfolio strategy, and commercial operations.Dr. Borinshteyn holds an MD and PhD in immunology and completed executive education at The Wharton School and Harvard Business School.